# FDA recall D-0492-2017

> **Mylan Pharmaceuticals Inc.** · Class II · drug recall initiated 2017-01-19.

## Product

Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV

## Reason for recall

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0492-2017
- **Recalling firm:** Mylan Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-01-19
- **Report date:** 2017-03-15
- **Termination date:** 2017-07-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Morgantown, WV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0492-2017

## Citation

> AI Analytics. FDA recall D-0492-2017. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0492-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*